Want to see VTGN full AI Analyst Report?
VistaGen Therapeutics (VTGN) Revenue
1,156 Followers
VistaGen Therapeutics Revenue
VistaGen Therapeutics had a revenue of 1.48M in the quarter ending Jun 30, 2026, with 217.42%. This bring the company's revenue in the last twelve months to 2.50M, Increased 97.01%. In the fiscal year ending Mar 31, 2026, VistaGen Therapeutics had annual revenue of 1.27M with 161.11% growth.
- Revenue (ttm)
- 2.50M
- Revenue Growth
- ―
- P/S Ratio
- 6.44
- Revenue/Employee
- $30,951
- Employees
- 41
- Market Cap
- $8.18M
Revenue Chart
VistaGen Therapeutics Revenue - Annual
Revenue History
| Fiscal End Date | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 1.27M | 783.00K | 161.11% |
| Mar 31, 2025 | 486.00K | -578.00K | -54.32% |
| Mar 31, 2024 | 1.06M | 1.29M | -568.72% |
| Mar 31, 2023 | -227.00K | -1.34M | -120.47% |
| Mar 31, 2022 | 1.11M | 19.40K | 1.78% |
| Mar 31, 2021 | 1.09M | 1.09M | ― |
| Mar 31, 2020 | 0.00 | 0.00 | ― |
| Mar 31, 2019 | 0.00 | 0.00 | ― |
| Mar 31, 2018 | 0.00 | -1.25M | -100.00% |
| Mar 31, 2017 | 1.25M | ― | ― |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.